Synthesis and ReactiVity of the [TaCp*Me3]+ Cation
Organometallics, Vol. 25, No. 9, 2006 2335
Finally, the cation complex [TaCp*Me3]+ was active for
ethylene polymerization, although it showed rather low catalytic
activity.
[TaCp*Me(OCHMePh)2][MeB(C6F5)3] (5). PhC(O)H (0.058
g, 0.54 mmol) was added to a solution of [TaCp*Me3][MeB(C6F5)3]
(1; 0.26 mmol) in CH2Cl2 (5 mL), prepared in situ. After the mixture
was stirred for 6 h, the volatiles were removed under vacuum and
the remaining oil was washed first with toluene and then with
hexane to give 5 (0.26 g, 89%). Data for 5: 1H NMR (CD2Cl2)
0.50 (bs, 6 H, Me-B, 5a and 5b), 1.07 (s, 3 H, Me-Ta, 5a), 1.17
(s, 3 H, Me-Ta, 5b), 1.56 (d, 3 H, 3J(H-H) ) 6.5 Hz, Me-C-O,
Experimental Section
General Considerations. All manipulations were carried out
under an argon atmosphere, and solvents were distilled from
appropriate drying agents. NMR spectra were recorded at 300.13
(1H), 188.31 (19F), and 75.47 (13C) MHz at room temperature on a
Varian Unity 300. The 13C NMR data for the methyl group of the
[MeB(C6F5)3] anion was observed by gHMQC experiments.
Chemical shifts (δ) are given in ppm relative to internal TMS (1H
and 13C) or external CFCl3 (19F). Elemental analyses were performed
on a Perkin-Elmer 240C. The compounds [TaCp*Me4],14 B(C6F5)3,38
and [H2O‚B(C6F5)3]39 were prepared by literature methods. PhC-
(O)H and PhNCO were distilled from CaH2 and P2O5, respectively,
under vacuum and stored under argon.
[TaCp*Me3][MeB(C6F5)3] (1). [TaCp*Me4] (0.100 g, 0.26
mmol) and B(C6F5)3 (0.150 g, 0.29 mmol) were stirred in toluene
(5 mL) for 5 min. The solution was then filtered off, leaving an oil
that was washed with hexane (5 mL), to give 1 as a brownish oil
(0.20 g, 85%). Data for 1: 1H NMR (CD2Cl2) 0.47 (bs, 3 H, Me-
B), 1.36 (s, 9 H, Me-Ta), 2.26 (s, 15 H, C5Me5); 13C NMR
(CD2Cl2) 10.4 (MeB(C6F5)3), 12.2 (C5Me5), 86.8 (Me-Ta), 125.3
(C5Me5), 136.4 (m, C6F5), 137.9 (m, C6F5), 148.7 (m, C6F5); 19F
NMR (CD2Cl2) -130.0 (o-C6F5), -162.1 (p-C6F5), -164.7 (m-
C6F5). Anal. Calcd for C32H27BF15Ta (888.29): C, 43.27; H, 3.06.
Found: C, 43.63; H, 3.14.
[TaCp*Me3(py)][MeB(C6F5)3] (2). Pyridine (0.021 g, 0.26
mmol) was added to a suspension of [TaCp*Me3][MeB(C6F5)3] (1;
0.26 mmol) in toluene (5 mL), prepared in situ. After the mixture
was stirred for 10 min, the solution was filtered off and the
remaining oil was washed with hexane (5 mL) to give 2 (0.21 g,
83%). Data for 2: 1H NMR (CD2Cl2) 0.47 (s, 3 H, Me-B), 0.50
(s, 9 H, Me-Ta), 2.26 (s, 15 H, C5Me5), 7.52 (m, 2 H, m-C5H5N),
7.91 (m, 1 H, p-C5H5N), 8.77 (m, 2 H, o-C5H5N); 13C NMR
(CD2Cl2) 10.7 (MeB(C6F5)3), 11.7 (C5Me5), 76.5 (Me-Ta), 121.5
(C5Me5), 125.8 (p-C5H5N), 135.7 (m, C6F5), 139.0 (m, C6F5), 139.3
(m-C5H5N), 148.2 (m, C6F5), 149.4 (o-C5H5N); 19F NMR (CD2Cl2)
-130.0 (o-C6F5), -162.1 (p-C6F5), -164.7 (m-C6F5). Anal. Calcd
for C37H32BF15NTa (967.39): C, 45.94; H, 3.33; N, 1.45. Found:
C, 45.38; H, 3.10; N, 1.29.
3
5b), 1.67 (d, 3 H, J(H-H) ) 6.5 Hz, Me-C-O, 5b), 1.72 (d, 6
H, 3J(H-H) ) 6.5 Hz, Me-C-O, 5a), 2.02 (s, 15 H, C5Me5, 5a),
2.05 (s, 15 H, C5Me5, 5b), 5.60-5.79 (m, 4 H, H-C-O), 7.15-
7.50 (m, 10 H, C6H5); 13C NMR (CD2Cl2) 10.6 (MeB(C6F5)3), 10.9
(C5Me5), 24.6 (Me-C-O, 5b), 25.0 (Me-C-O, 5b), 25.1 (Me-
C-O, 5a), 43.1 (Me-Ta), 43.7 (Me-Ta), 87.2 (C-O), 87.3 (C-
O), 87.4 (C-O), 124.6, 124.7, 126.0, 129.5, 129.6, 129.7, 129.8,
141.1, 141.2 (C6H5 and C5Me5), 136.8 (m, C6F5), 137.9 (m, C6F5),
148.2 (m, C6F5); 19F NMR (CD2Cl2) -131.3 (o-C6F5), -162.0 (p-
C6F5), -164.7 (m-C6F5). Anal. Calcd for C46H39BF15O2Ta
(1100.54): C, 50.20; H, 3.57. Found: C, 49.95; H, 3.48.
[TaCp*Me3(OCHMePh)] (6). A solution of [TaCp*Me4] (0.300
g, 0.78 mmol) and PhC(O)H (0.120 g, 1.20 mmol) in toluene (5
mL) was heated at 70 °C for 24 h. Afterward, the volatiles were
removed under vacuum and hexane was added (15 mL). The
solution was filtered and the filtrate was concentrated to a volume
of ca. 4 mL and cooled to -40 °C, yielding 6 as yellow crystals
(0.25 g, 65%). Data for 6: 1H NMR (CDCl3) 0.06 (s, 6 H, Me-
Ta), 0.17 (s, 3 H, Me-Ta), 1.55 (d, 3 H, 3J(H-H) ) 6.4 Hz, Me-
3
C-O), 1.86 (s, 15 H, C5Me5), 5.40 (q, 1 H, J(H-H) ) 6.4 Hz,
H-C-O), 7.30 (m, 5 H, C6H5); 13C NMR (CDCl3) 11.0 (C5Me5),
25.4 (Me-C-O), 50.5 (Me-Ta), 50.8 (Me-Ta), 53.2 (Me-Ta),
81.4 (C-O), 115.9 (C5Me5), 125.9, 127.1, 128.1, and 145.3 (C6H5).
Anal. Calcd for C21H33OTa (482.43): C, 52.28; H, 6.89. Found:
C, 52.10; H, 6.70.
[TaCp*Me2{OC(Me)NPh}][MeB(C6F5)3] (7). PhNCO (0.040
mmol) was added to a solution of [TaCp*Me3][MeB(C6F5)3] (1;
0.040 mmol) in CD2Cl2, prepared in situ. The reaction was
monitored by NMR until it was finished after 30 min, showing the
remaining unreacted 1 and the formation of 7 and 8. Data for 7:
1H NMR (CD2Cl2) 0.47 (bs, 3 H, Me-B), 0.95 (s, 6 H, Me-Ta),
2.18 (s, 15 H, C5Me5), 2.23 (s, 3 H, Me-C-O), 7.24-7.60 (C6H5,
underneath with those corresponding with compound 8); 13C NMR
(CD2Cl2) 10.5 (MeB(C6F5)3), 11.0 (C5Me5), 18.6 (Me-C-O), 77.1
(Me-Ta), 124.9, 125.4, 128.5, 130.5 and 139.3 (C6H5 and C5Me5),
135.7 (m, C6F5), 138.9 (m, C6F5), 148.5 (m, C6F5), 187.7 (C-O);
19F NMR (CD2Cl2) -130.5 (o-C6F5), -162.5 (p-C6F5), -165.1 (m-
C6F5).
Reaction of [TaCp*Me3][MeB(C6F5)3] (1) with H2O‚B(C6F5)3.
A Teflon-valved NMR tube was charged with a solution of 1 (0.018
g, 0.020 mmol) and H2O‚B(C6F5)3 (0.005 g, 0.010 mmol) in CD2-
1
Cl2. After 3 h, the H NMR spectrum revealed that the reactants
had been transformed into [TaCp*Me2{O‚B(C6F5)3}]34 and B(C6F5)3,
with minor amounts of other unidentified products.
[TaCp*Me{OC(Me)NPh}2][MeB(C6F5)3] (8). PhNCO (0.056
g, 0.56 mmol) was added to a solution of [TaCp*Me3][MeB(C6F5)3]
(1; 0.26 mmol) in CH2Cl2 (5 mL), prepared in situ. After the mixture
was stirred for 3 h, the volatiles were removed under vacuum and
the remaining oil was washed first with toluene and then with
hexane to give 8 (0.27 g, 89%). Data for 8: 1H NMR (CD2Cl2)
0.47 (bs, 3 H, Me-B), 1.05 (s, 3 H, Me-Ta), 1.98 (s, 6 H, Me-
C-O), 2.27 (s, 15 H, C5Me5), 6.66 (bs, 2 H, C6H5), 7.34 (m, 8 H,
C6H5); 13C NMR (CD2Cl2) 10.5 (MeB(C6F5)3), 11.1 (C5Me5), 20.2
(Me-C-O), 67.3 (Me-Ta), 124.7 (C5Me5), 127.3, 128.3, 130.1,
and 139.9 (C6H5), 135.5, 139.9, and 148.7 (m, C6F5), 184.5 (C-
O); 19F NMR (CD2Cl2) -130.4 (o-C6F5), -162.5 (p-C6F5), -165.1
(m-C6F5). Anal. Calcd for C46H37BF15N2O2Ta (1126.53): C, 49.04;
H, 3.31; N, 2.49. Found: C, 49.35; H, 3.48; N, 2.27.
[TaCp*Me2(OCHMePh)][MeB(C6F5)3] (4). PhC(O)H (0.028
g, 0.26 mmol) was added to a solution of [TaCp*Me3][MeB(C6F5)3]
(1; 0.26 mmol) in CH2Cl2 (5 mL), prepared in situ. After the mixture
was stirred for 1 h, the volatiles were removed under vacuum and
the remaining oil was washed first with toluene (5 mL) and then
with hexane (5 mL) to give 4 (0.23 g, 87%). Data for 4: 1H NMR
(CD2Cl2) 0.47 (bs, 3 H, Me-B), 0.93 (s, 3 H, Me-Ta), 1.02 (s, 3
H, Me-Ta), 1.90 (d, 3 H, 3J(H-H) ) 6.5 Hz, Me-C-O), 2.09 (s,
3
15 H, C5Me5), 5.87 (q, 1 H, J(H-H) ) 6.5 Hz, H-C-O), 7.38
(m, 2 H, m-C6H5), 7.46 (m, 3 H, p-C6H5 and o-C6H5); 13C NMR
(CD2Cl2) 10.5 (MeB(C6F5)3), 11.2 (C5Me5), 24.7 (Me-C-O), 67.1
(Me-Ta), 67.2 (Me-Ta), 89.2 (C-O), 125.3, 126.1, 129.8, 130.3
(C6H5 and C5Me5), 135.7 (m, C6F5), 139.0 (m, C6F5), 140.5 (o-
C6H5), 148.2 (m, C6F5); 19F NMR (CD2Cl2) -131.3 (o-C6F5),
-162.0 (p-C6F5), -164.7 (m-C6F5). Anal. Calcd for C39H33BF15-
OTa (994.41): C, 47.10; H, 3.34. Found: C, 47.20; H, 3.48.
[(TaCp*Me3)2(µ-O)] (9). A solution of [TaCp*Me4] (0.300 g,
0.78 mmol) and PhNCO (0.095 g, 0.78 mmol) in toluene (5 mL)
was heated at 90 °C for 24 h. Afterward, the volatiles were removed
under vacuum and hexane was added (10 mL). The solution was
filtered off, leaving a pale orange solid that was identified as 933
(0.24 g, 80%). Data for 9: 1H NMR (CDCl3) 0.36 (s, 3 H, Me-
(39) Doerrer, L. H.; Green, M. L. H. Dalton Trans. 1999, 4325.